Understanding lymphoma: Get the facts at a free virtual education event on Sept. 28

Understanding lymphoma: Get the facts at a free virtual education event on Sept. 28

On Sept. 28, join Asian Health & Service Center and Providence Cancer Institute of Oregon for a free, virtual patient education talk given by Natasha Edwin, M.D., hematologist, medical oncologist at Providence Cancer Institute. 

Dr. Edwin will share current information about different types of lymphoma, as well as: 

  • Risk factors  
  • Symptoms 
  • Diagnosis 
  • Treatment options and side effects 
  • Find out what questions to ask your doctor and where to find community resources. 

Learn more about this free virtual educational talk and other community events.  

Lymphoma: The Basics and Beyond 
Wednesday, Sept. 28 
3:00 - 4:30 p.m. 
Get your Zoom registration today. 

About Dr. Natasha Edwin

Dr. Natasha Edwin is a hematologist and medical oncologist at Providence Oncology and Hematology Care Clinic - Westside and specializes in the treatment of patients with blood cancer and blood disorders.

Dr. Edwin is passionate about putting her patients at ease by personalizing treatments, aligning them with their own values, and empowering them with the knowledge they need to make informed decisions about their care. She is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Edwin is a strong proponent of participation in clinical trials. She has served on the Leukemia Committee of the Eastern Cooperative Oncology Group and on the Board of Directors for the Alliance for Clinical trials in Oncology.

Experienced care for patients with cancer and blood disorders 

The Providence Hematologic Malignancies Program provides compassionate care for cancers of the blood, bone marrow and lymph nodes. We combine the most advanced therapies with new research to use your body's own immune system to fight cancer.

Our team of physicians are experts in hematologic malignancies including Hodgkin and non-Hodgkin lymphomas, leukemia, multiple myeloma and the myelodysplastic syndromes. We use a team approach to care because we know you’ll benefit most when you have the knowledge of many different specialists guiding your treatment. Learn more.

Related news

Multi-indication clinical trials help evaluate new medications for future treatments

Study to evaluate effect of immunotherapy in blood cancer